Document is current
Any future updates will be listed below
-
Authors
Tadros, Rafik https://orcid.org/0000-0002-1472-0258
Francis, Catherine
Xu, Xiao
Vermeer, Alexa M. C.
Harper, Andrew R. https://orcid.org/0000-0001-5327-0328
Huurman, Roy https://orcid.org/0000-0001-7405-8668
Kelu Bisabu, Ken https://orcid.org/0000-0003-1453-177X
Walsh, Roddy https://orcid.org/0000-0001-5092-8825
Hoorntje, Edgar T.
te Rijdt, Wouter P.
Buchan, Rachel J. https://orcid.org/0000-0003-2490-9289
van Velzen, Hannah G.
van Slegtenhorst, Marjon A.
Vermeulen, Jentien M.
Offerhaus, Joost Allard
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
de Marvao, Antonio
Lahrouchi, Najim https://orcid.org/0000-0003-1753-452X
Beekman, Leander
Karper, Jacco C.
Veldink, Jan H. https://orcid.org/0000-0001-5572-9657
Kayvanpour, Elham
Pantazis, Antonis
Baksi, A. John
Whiffin, Nicola https://orcid.org/0000-0003-1554-6594
Mazzarotto, Francesco https://orcid.org/0000-0002-6159-9980
Sloane, Geraldine
Suzuki, Hideaki https://orcid.org/0000-0002-0410-6940
Schneider-Luftman, Deborah
Elliott, Paul https://orcid.org/0000-0002-7511-5684
Richard, Pascale
Ader, Flavie https://orcid.org/0000-0001-7891-3385
Villard, Eric
Lichtner, Peter
Meitinger, Thomas https://orcid.org/0000-0002-8838-8403
Tanck, Michael W. T. https://orcid.org/0000-0001-9828-4459
van Tintelen, J. Peter https://orcid.org/0000-0003-3854-6749
Thain, Andrew
McCarty, David
Hegele, Robert A. https://orcid.org/0000-0003-2861-5325
Roberts, Jason D.
Amyot, Julie
Dubé, Marie-Pierre https://orcid.org/0000-0001-8442-4393
Cadrin-Tourigny, Julia
Giraldeau, Geneviève
L’Allier, Philippe L.
Garceau, Patrick
Tardif, Jean-Claude
Boekholdt, S. Matthijs
Lumbers, R. Thomas https://orcid.org/0000-0002-9077-4741
Asselbergs, Folkert W. https://orcid.org/0000-0002-1692-8669
Barton, Paul J. R. https://orcid.org/0000-0002-1165-7767
Cook, Stuart A.
Prasad, Sanjay K.
O’Regan, Declan P. https://orcid.org/0000-0002-0691-0270
van der Velden, Jolanda https://orcid.org/0000-0001-5224-5788
Verweij, Karin J. H. https://orcid.org/0000-0001-9868-7821
Talajic, Mario
Lettre, Guillaume
Pinto, Yigal M. https://orcid.org/0000-0002-2836-571X
Meder, Benjamin
Charron, Philippe https://orcid.org/0000-0002-1782-1118
de Boer, Rudolf A. https://orcid.org/0000-0002-4775-9140
Christiaans, Imke
Michels, Michelle
Wilde, Arthur A. M.
Watkins, Hugh https://orcid.org/0000-0002-5287-9016
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
Ware, James S. https://orcid.org/0000-0002-6110-5880
Bezzina, Connie R. https://orcid.org/0000-0002-0633-3514
- License Information
-
More Information
Article History
Received: 28 February 2020
Accepted: 10 December 2020
First Online: 25 January 2021
Competing interests
: M.-P.D. is author on a patent pertaining to pharmacogenomics-guided CETP inhibition (US20170233812A1), has a minor equity interest in DalCor and has received honoraria from Dalcor and Servier and research support (access to samples and data) from AstraZeneca, Pfizer, Servier, Sanofi and GlaxoSmithKline. J.-C.T. has received research grants from Amarin, AstraZeneca, DalCor, Esperion, Ionis, Sanofi and Servier; honoraria from AstraZeneca, DalCor, HLS, Sanofi and Servier; holds minor equity interest in DalCor; and is an author of a patent on pharmacogenomics-guided CETP inhibition (US20170233812A1). B.M. has received research funding from Siemens Healtheneers, Daiichi Sankyo. The UMCG, which employs R.A.d.B., has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk and Roche. R.A.d.B. received speaker fees from Abbott, AstraZeneca, Novartis and Roche. HW is a consultant for Cytokinetics. P.M.M. receives an honorarium as Chair of the UKRI Medical Research Council Neuroscience and Mental Health Board. He acknowledges consultancy fees from Adelphi Communications, MedScape, Neurodiem, Nodthera, Biogen, Celgene and Roche. He has received speakers’ honoraria from Celgene, Biogen, Novartis and Roche, and has received research or educational funds from Biogen, GlaxoSmithKline and Novartis. He is paid as a member of the Scientific Advisory Board for Ipsen Pharmaceuticals. J.S.W. has received research support and consultancy fees from Myokardia, Inc.
